NCT01418989View on ClinicalTrials.gov

A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

239

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Healthy Volunteer

Interventions

DRUG

tocilizumab [RoActemra/Actemra] Syringe

Single dose administration with pre-filled syringe

DRUG

tocilizumab [RoActemra/Actemra] auto-injector

Single dose administration with auto-injector

Trial Locations (2)

34094

Montpellier

35042

Rennes

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01418989 - A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers | Biotech Hunter | Biotech Hunter